Ulla Axdorph Nygell

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: BONE MARROW TRANSPLANTATION. 2022;57(5):795-802
Cancer incidence in healthy Swedish peripheral blood stem cell donors
Pahnke S; Nygell UA; Johansson J-E; Kisch A; Ljungman P; Sandstedt A; Hagglund H; Larfors G
Article: VOX SANGUINIS. 2019;114(7):769-777
Granulocyte transfusions could benefit patients with severe oral mucositis after allogeneic hematopoietic stem cell transplantation
Berglund S; Watz E; Remberger M; Legert KG; Axdorph-Nygell U; Sundin M; Uhlin M; Mattsson J
Article: CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY. 2019;44(1):84-91
Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis
Afram G; Watz E; Remberger M; Nygell UA; Sundin M; Hagglund H; Mattsson J; Uhlin M
Article: JOURNAL OF CLINICAL APHERESIS. 2018;33(3):226-235
Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors
Pahnke S; Larfors G; Axdorph-Nygell U; Fischer-Nielsen A; Haastrup E; Heldal D; Itala-Remes M; Johansson J-E; Kauppila M; Lenhoff S; Ljungman P; Niittyvuopio R; Sandstedt A; Hagglund H
Article: TRANSFUSION. 2018;58(6):1442-1451
Change of apheresis device decreased the incidence of severe acute graft-versus-host disease among patients after allogeneic stem cell transplantation with sibling donors
Wang T; Remberger M; Nygell UA; Sundin M; Bjorklund A; Mattsson J; Uhlin M; Watz E
Article: JOURNAL OF CLINICAL APHERESIS. 2017;32(6):384-391
G-CSF mobilized peripheral blood stem cell collection for allogeneic transplantation in healthy donors: Analysis of factors affecting yield
Machaczka M; Hagglund H; Staver E; Joks M; Hassan M; Wahlin BE; Nygell UA
Article: JOURNAL OF CLINICAL APHERESIS. 2015;30(5):265-272
Eighteen Years Experience of Granulocyte Donations-Acceptable Donor Safety?
Nygell UA; Sollen-Nilsson A; Lundahl J
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2013;45(2):112-116
Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection
Cherif H; Axdorph U; Kalin M; Bjorkholm M
Article: MEDICAL ONCOLOGY. 2012;29(3):2191-2199
Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery
Ungerstedt JS; Watz E; Uttervall K; Johansson B-M; Wahlin BE; Nasman P; Ljungman P; Gruber A; Nygell UA; Nahi H
Article: BLOOD. 2012;119(4):990-996
Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009
Sjoberg J; Halthur C; Kristinsson SY; Landgren O; Nygell UA; Dickman PW; Bjorkholm M
Article: BONE MARROW TRANSPLANTATION. 2010;45(8):1269-1273
Family donor care management: principles and recommendations
van Walraven SM; Nicoloso-de Faveri G; Axdorph-Nygell UAI; Douglas KW; Jones DA; Lee SJ; Pulsipher M; Ritchie L; Halter J; Shaw BE
Article: VOX SANGUINIS. 2010;98(4):567-575
Preparation of granulocyte concentrates by apheresis.
Leitner G; Panzer S; Reesink HW; Stiegler G; Fischer-Nielsen A; Dickmeiss E; Einsele H; Reinhardt P; Schrezenmeier H; Wiesneth M; Coluccia P; Nygell UA; Halter J; Sigle J; Gratwohl A; Buser AS; Ozturk G; Anak S
Article: THERAPEUTIC APHERESIS AND DIALYSIS. 2008;12(5):347-354
Recognition of intercenter differences may help develop best practice.
Norda R; Axelsson CG; Axdorph U; Berlin G; Wikström B; Stegmayr B; Swedish Apheresis Group
Article: ANNALS OF ONCOLOGY. 2006;17(8):1290-1295
A population-based cohort study on early-stage Hodgkin lymphoma treated with radiotherapy alone:: with special reference to older patients
Landgren O; Axdorph U; Fears TR; Porwit-MacDonald A; Wedelin C; Bjorkholm M
Article: ANNALS OF HEMATOLOGY. 2005;84(3):150-158
Characterization of red cell autoantibodies in consecutive DAT-positive patients with relation to in vivo haemolysis
Wikman A; Axdorph U; Gryfelt G; Gustafsson L; Björkholm M; Lundahl J
Article: QUALITY OF LIFE RESEARCH. 2004;13(8):1369-1379
Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma
Wettergren L; Björkholm M; Axdorph U; Langius-Eklöf A
Article: JOURNAL OF INTERNAL MEDICINE. 2004;255(6):664-673
A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma
Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
Article: HEMATOLOGY JOURNAL. 2004;5(1):69-76
A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomas
Landgren O; MacDonald AP; Tani E; Czader M; Grimfors G; Skoog L; Öst A; Wedelin C; Axdorph U; Svedmyr E; Björkholm M
Article: QUALITY OF LIFE RESEARCH. 2003;12(5):545-554
Individual quality of life in long-term survivors of Hodgkin's lymphoma -: a comparative study
Wettergren L; Björkholm M; Axdorph U; Bowling A; Langius-Eklöf A
Article: HAEMATOLOGICA. 2003;88(4):438-444
Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis
Landgren O; Algernon C; Axdorph U; Nilsson B; Wedelin C; Porwit-MacDonald A; Grimfors G; Björkholm M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;118(4):1048-1054
Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase -: a report from the Swedish CML Group
Axdorph U; Stenke L; Grimfors G; Carneskog J; Hansen J; Linder O; Ljungman P; Löfvenberg E; Malm C; Simonsson B; Turesson I; Vilén L; Udén AM; Björkholm M
Article: HAEMATOLOGICA. 2002;87(6):596-601
Parental longevity and survival in elderly patients with Hodgkin's lymphoma
Landgren O; Askling J; Dickman PW; Ösby E; Axdorph U; Ekbom A; Björkholm M
Article: APMIS. 2002;110(5):379-390
T-cell-rich B-cell lymphoma - diagnostic and therapeutic aspects
Axdorph U; Porwit-MacDonald A; Sjoberg J; Grimfors G; Bjorkholm M
Article: LEUKEMIA & LYMPHOMA. 2001;42(5):1055-1065
Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease
Axdorph U; Porwit-MacDonald A; Grimfors G; Björkholm M
Article: ANNALS OF ONCOLOGY. 2000;11(11):1405-1411
Biological markers may add to prediction of outcome achieved by the international prognostic score in Hodgkin's disease
Axdorph U; Sjöberg J; Grimfors G; Landgren O; Porwit-MacDonald A; Björkholm M
Article: MEDICAL ONCOLOGY. 2000;17(3):174-178
Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin's disease
Landgren O; Axdorph U; Jacobsson H; Johansson B; Grimfors G; Björkholm M
Article: BRITISH JOURNAL OF CANCER. 1999;81(7):1182-1187
Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function
Axdorph U; Porwit-MacDonald A; Sjöberg J; Grimfors G; Ekman M; Wang W; Biberfeld P; Björkholm M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1999;104(2):346-349
Tumour necrosis factor-α cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukaemia
Wihlborg C; Sjöberg J; Intaglietta M; Axdorph U; Pisa EK; Pisa P
Article: ANNALS OF ONCOLOGY. 1995;6(9):895-899
Fired versus response-adapted MOPP/ABVD chemotherapy in Hodgkin's disease - A prospective randomized trial
Bjorkholm M; Axdorph U; Grimfors G; Merk K; Johansson B; Landgren O; Svedmyr E; Mellstedt H; Holm G
Article: JOURNAL OF INTERNAL MEDICINE. 1995;237(2):205-209
LEUKOCYTE DOUBLING TIME IS A USEFUL PREDICTOR OF PROGRESSION-FREE SURVIVAL IN CHRONIC LYMPHOCYTIC-LEUKEMIA
AXDORPH U; NILSSON BI; NILSSON BR; BJORKHOLM M
Visa fler

Alla övriga publikationer

Other: LAKARTIDNINGEN. 2018;115:E6CC
Replik gällande granulocyttransfusion: - Rekommendationerna är väl underbyggda.
Berlin G; Cherif H; Knutson F; Mattsson J; Axdorph Nygell U
Review: LAKARTIDNINGEN. 2018;115:EXUU
[Granulocyte transfusion – when and how should it be used?].
Berlin G; Cherif H; Knutson F; Mattsson J; Axdorph Nygell U
Letter: BLOOD. 2016;128(9):1302-1305
Adsorptive depletion of blood monocytes reduces the levels of circulating interleukin-17A in Langerhans cell histiocytosis
Lourda M; Olsson-Akefeldt S; Gavhed D; Nygell UA; Berlin G; Laurencikas E; Greenwood TVB; Svensson M; Henter J-I
Letter: BLOOD. 2013;121(23):4807
Development of Hodgkin lymphoma in homozygotic triplets with constitutional deletion in MKL1
Bjorkholm M; Sjoberg J; Nygell UA; Porwit A; Bjorck E
Published conference paper: ANNALS OF ONCOLOGY. 2002;13:86-91
Early response to chemotherapy:: a surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity?
Carde P; Koscielny S; Franklin J; Axdorph U; Raemaekers J; Diehl V; Aleman B; Brosteanu O; Hasenclever D; Oberlin O; Bonvin N; Björkholm M
Thesis / dissertation: 2001
Clinical and immunopathological studies in Hodgkin's disease with special reference to prognosis
Axdorph, Ulla

Anställningar

Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2024-2025

Examina och utbildning

Docent, transfusionsmedicin, Karolinska Institutet, 2017
MEDICINE DOKTORSEXAMEN, Institutionen för medicin, Solna, Karolinska Institutet, 2001

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI